Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Total Debt: 2016-2025

Historic Total Debt for Collegium Pharmaceutical (COLL) over the last 10 years, with Sep 2025 value amounting to $570.2 million.

  • Collegium Pharmaceutical's Total Debt fell 9.54% to $570.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 billion, marking a year-over-year increase of 38.48%. This contributed to the annual value of $615.3 million for FY2024, which is 51.91% up from last year.
  • Collegium Pharmaceutical's Total Debt amounted to $570.2 million in Q3 2025, which was down 2.57% from $585.2 million recorded in Q2 2025.
  • In the past 5 years, Collegium Pharmaceutical's Total Debt registered a high of $630.3 million during Q3 2024, and its lowest value of $110.0 million during Q4 2021.
  • Its 3-year average for Total Debt is $505.7 million, with a median of $537.1 million in 2023.
  • As far as peak fluctuations go, Collegium Pharmaceutical's Total Debt skyrocketed by 409.07% in 2022, and later plummeted by 35.90% in 2024.
  • Quarterly analysis of 5 years shows Collegium Pharmaceutical's Total Debt stood at $110.0 million in 2021, then soared by 409.07% to $560.1 million in 2022, then dropped by 27.68% to $405.0 million in 2023, then skyrocketed by 51.91% to $615.3 million in 2024, then fell by 9.54% to $570.2 million in 2025.
  • Its Total Debt stands at $570.2 million for Q3 2025, versus $585.2 million for Q2 2025 and $600.3 million for Q1 2025.